tiprankstipranks
Bionik Laboratories Corp (BNKL)
OTHER OTC:BNKL
US Market

Bionik Laboratories (BNKL) Cash flow

10 Followers

Bionik Laboratories Cash Flow

BNKL's free cash flow for Q4 2023 was $―. For the 2023 fiscal year, BNKL's free cash flow was decreased by $772.47K and operating cash flow was $-756.94K. See a summary of the company’s cash flow.
Cash Flow
TTM
Mar 23Mar 22Mar 21Mar 20Mar 19
Operating Cash Flow
$ -2.87M$ -3.39M$ -4.15M$ -4.62M$ -9.06M$ -9.23M
Investing Cash Flow
$ -222.93K$ -223.69K$ -12.50K-$ -159.65K$ -101.78K
Financing Cash Flow
$ 1.25M$ 2.05M$ 5.55M$ 2.96M$ 11.05M$ 9.27M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 2.10M$ 427.38K$ 1.99M$ 608.35K$ 2.27M$ 446.78K
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
------
Issuance Of Debt
$ 1.25M$ 2.05M$ 5.55M$ 2.96M$ 11.57M$ 9.33M
Repayment Of Debt
----$ -523.83K$ -50.00K
Free Cash Flow
$ -2.12M$ -3.39M$ -4.16M$ -4.62M$ -9.22M$ -9.33M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Bionik Laboratories Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis